CD Bioparticles

Nanomedicine CDMO Services

The development and manufacturing of nanomedicines may pose significant challenges, including achieving consistent nanoparticle sizes, customizing physical and biological functional properties, expanding production while maintaining quality, and addressing complex regulatory requirements such as cGMP compliance. In addition, designing a delivery system and striving for formula optimization to ensure effective targeting and controlled release requires high technical requirements. Nanoparticle formulation is our focus, which sets us apart from traditional formulation development services.

Unrivaled Technical Expertise

At CD Bioparticles, our nanomedicine CDMO services are built upon extensive expertise in nanoparticle manufacturing, characterization, and development, coupled with our ability to provide innovative solutions for complex challenges. We provide personalized attention for your project to ensure the repeatability of nanoparticles, verify particle specifications, and expand production scale for commercialization. Whether your particles are active pharmaceutical ingredients, excipients, or delivery components, we will provide support for your project from early research and development to preclinical studies, and then to the first and second stages of manufacturing. Our integrated CDMO solution can accelerate the commercialization of your nanomedicine innovation while reducing risks.

Our Services

CD Bioparticles focuses on the research, development, and scalable production of nanoparticle therapy. With our expertise in nanoparticle formulation, process optimization, and GMP manufacturing, we support pharmaceutical companies, biotechnology companies, and academic researchers in bringing innovative nanomedicine from concept to clinical practice. By collaborating with us, you can gain access to cutting-edge nanotechnology platforms, regulatory expertise, and a team dedicated to accelerating your nanomedicine projects.

Nanoparticle Contract R&D - Tailored Formulation & Preclinical Development

Our Nanoparticle Contract R&D services focus on designing, formulating, and optimizing advanced nanocarriers for drug delivery, diagnostics, and theranostics. We work with a variety of nanoparticle systems, including:

  • Lipid Nanoparticles (LNPs) – For mRNA, siRNA, and gene therapy applications.
  • Polymeric Nanoparticles – PLGA, chitosan, and other biodegradable polymers for sustained release.
  • Metal & Inorganic Nanoparticles – Gold, silica, and iron oxide nanoparticles for imaging and therapy.
  • Exosomes & Extracellular Vesicles – Natural nanocarriers for targeted delivery.

Key R&D Services

  • Formulation Screening & Optimization – High-throughput screening of excipients and conditions.
  • Drug Loading & Encapsulation Efficiency Studies – Maximizing payload capacity.
  • Stability & Characterization – Particle size (DLS), zeta potential, TEM/SEM, and in vitro release.
  • In Vitro & In Vivo Testing – Cell-based assays, biodistribution, pharmacokinetics (PK), and efficacy studies.

Nanoparticle Contract Process Development – Scalable & Robust Manufacturing

Transitioning from bench-scale nanoparticle formulations to GMP-ready processes requires expertise in nanomanufacturing, quality by design (QbD), and process analytical technology (PAT). Our nanoparticle contract process development services ensure your nanoparticle therapeutics are reproducible, scalable, and compliant.

Process Development Capabilities

  • Scale-Up Feasibility Studies – From microfluidics to high-pressure homogenization
  • QbD-Based Process Optimization – Identifying critical process parameters (CPPs)
  • Lyophilization & Stabilization – Enhancing nanoparticle shelf-life
  • Tech Transfer Support – Seamless transition to GMP manufacturing

Key Technologies & Methods

  • Microfluidics & Nanoassemblies – Precise control over particle characteristics
  • High-Pressure Homogenization (HPH) – Scalable production of liposomes and LNPs
  • Spray Drying & Freeze-Drying – Solid dosage forms for improved stability

Nanoparticle Contract Manufacturing – cGMP-Compliant Production

Our nanoparticle contract manufacturing services provide FDA/EMA-compliant production of nanotherapeutics for Phase I-III trials and commercial supply. With state-of-the-art cleanrooms and stringent quality control, we ensure your products meet the highest standards.

Manufacturing Services Include:

  • Lipid Nanoparticles (LNPs) for mRNA & Gene Therapy
  • Polymeric Nanoparticles (PLGA, PEGylated systems)
  • Liposomes & Niosomes
  • Nanocrystals & Nanoemulsions

Our Advantages

Flexible and Scalable Solutions

We offer flexible manufacturing solutions that can adapt to the changing needs of our clients. Whether you need a small batch for preclinical testing or large-scale production for commercialization, we have the capacity and expertise to deliver

Expertise and Experience

With a team of experienced scientists and engineers, we bring a wealth of knowledge and expertise in nanoparticle development and manufacturing. Our team has successfully supported numerous projects.

Commitment to Quality

We are committed to delivering high-quality nanoparticles that meet the highest standards of safety and efficacy. We continuously invest in new technologies and methodologies to stay at the forefront of nanomedicine innovation.

Workflow

Requirements Gathering

Design and Proposal

Synthesis and Optimization

Quality Control

Delivery

Summary

With a proven track record in nanoparticle drug delivery, we are your trusted partner for nanomedicine development and manufacturing. Whether you need early-stage R&D, scalable process development, or cGMP production, our team delivers innovative, high-quality solutions to accelerate your program. Contact us today to discuss your nanomedicine project!